Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 21, 2021 - Issue 8
Submit an article Journal homepage
334
Views
10
CrossRef citations to date
0
Altmetric
Review

Beyond chronic migraine: a systematic review and expert opinion on the off-label use of botulinum neurotoxin type-A in other primary headache disorders

Andreas A. Argyrioua Headache Outpatient Clinic, Department of Neurology, Saint Andrew’s State General Hospital of Patras, GreeceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2131-7114View further author information
ORCID Icon,
Dimos-Dimitrios Mitsikostasb 1 Department of Neurology, Aeginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, GreeceView further author information
,
Elisa Mantovanic Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, ItalyView further author information
,
Michail Vikelisd Headache Clinic, Mediterraneo Hospital, Glyfada, GreeceView further author information
&
Stefano Tamburinc Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, ItalyView further author information
Pages 923-944 | Received 07 Jun 2021, Accepted 19 Jul 2021, Published online: 18 Aug 2021

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Andreas A. Argyriou, Elisa Mantovani, Dimos-Dimitrios Mitsikostas, Michail Vikelis & Stefano Tamburin. (2022) A systematic review with expert opinion on the role of gepants for the preventive and abortive treatment of migraine. Expert Review of Neurotherapeutics 22:6, pages 469-488.
Read now

Articles from other publishers (9)

Andreas A. Argyriou, Emmanouil V. Dermitzakis, Georgia Xiromerisiou, Dimitrios Rallis, Panagiotis Soldatos, Pantelis Litsardopoulos & Michail Vikelis. (2023) Efficacy and safety of fremanezumab for migraine prophylaxis in patients with at least three previous preventive failures: Prospective, multicenter, real‐world data from a Greek registry. European Journal of Neurology 30:5, pages 1435-1442.
Crossref
Soonwook Kwon, Mi Ji Lee & Manho Kim. (2023) Epicranial headache part 1: Primary stabbing headache. Cephalalgia 43:2, pages 033310242211469.
Crossref
Emmanouil V. Dermitzakis, Aikaterini Kouroudi, Andreas A. Argyriou, Konstantinos C. Spingos, Konstantinos Bilias & Michail Vikelis. (2022) Results of a Web-Based Survey on 2105 Greek Migraine Patients—Second Part: Efficacy of Acute and Prophylactic Migraine Treatments and Corresponding Patients’ Reported Satisfaction. Medicina 59:1, pages 31.
Crossref
Andreas A. Argyriou, Emmanouil V. Dermitzakis, Georgia Xiromerisiou & Michail Vikelis. (2022) OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic Migraine. Toxins 14:12, pages 847.
Crossref
Parisa Gazerani. (2022) How Does Botulinum Toxin Inhibit Itch?. Toxins 14:10, pages 701.
Crossref
Emmanouil V. Dermitzakis, Michail Vikelis, George S. Vlachos & Andreas A. Argyriou. (2022) Assessing the Significance of the Circadian Time of Administration on the Effectiveness and Tolerability of OnabotulinumtoxinA for Chronic Migraine Prophylaxis. Toxins 14:5, pages 296.
Crossref
Negar Shaterian, Negin Shaterian, Aref Ghanaatpisheh, Farnaz Abbasi, Sara Daniali, Maryam Jalali Jahromi, Mohammad Sadegh Sanie & Amir Abdoli. (2022) Botox (OnabotulinumtoxinA) for Treatment of Migraine Symptoms: A Systematic Review. Pain Research and Management 2022, pages 1-15.
Crossref
亚辉 秦. (2022) Advances in Application of Botulinum Toxin Type A in Neurology. Advances in Clinical Medicine 12:03, pages 1679-1685.
Crossref
Yuri Chaves-Martins. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 532 547 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.